AGP Picks
View all

Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on May 14, 2026

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
Forge Nano Delivers Semiconductor Wafer Fab Equipment to Leading Fortune Global 500 Communications Company for Commercial Photonics Applications
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
Snail Games USA Explores Partnerships in One of Gaming’s Largest Markets with Gamescom LATAM Attendance
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
SPARC AI Inc. (OTC: SPAIF) Leading Out in Filling Gap, Developing Software-Only Drone System
Alarum to Release First Quarter 2026 Results and Host Conference Call on Thursday, May 28, 2026
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
Fusemachines Research Shows How Agentic AI Is Becoming Core to Enterprise Hiring
Cycurion Reports First Quarter 2026 Results
VivoPower CIO to Address Power Access and AI Infrastructure Financing at KBRA’s European Data Centers Event in London
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors
OrganOx Announces Appointment of Naoya Iwata as CEO & President
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Perceptyx Launches Develop, an AI Learning System That Measures Comprehension in Real Time

Share this page:

Sign up for:

Sci-Tech Seattle

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.